DrugPatentWatch Database Preview
Details for Patent: 10,092,525
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 10,092,525 protect, and when does it expire?
Patent 10,092,525 protects EPIDIOLEX and is included in one NDA.
This patent has ten patent family members in nine countries.
Summary for Patent: 10,092,525
| Title: | Use of cannabinoids in the treatment of epilepsy |
| Abstract: | The present disclosure relates to the use of cannabidiol (CBD) for the treatment of atonic seizures. In particular the CBD appears particularly effective in reducing atonic seizures in patients suffering with etiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; Aicardi syndrome; CDKL5 and Dup15q in comparison to other seizure types. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). |
| Inventor(s): | Guy; Geoffrey (London, GB), Wright; Stephen (London, GB), Mead; Alice (Cambridge, GB), Devinsky; Orrin (New York, NY) |
| Assignee: | GW Pharma Limited (Vision Park, Histon, Cambridge, GB) |
| Application Number: | 15/449,402 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,092,525
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | USE FOR THE TREATMENT OF DROP SEIZURES IN PATIENTS WITH DRAVET SYNDROME | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,092,525
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015332212 | Start Trial | |||
| Brazil | 112017007777 | Start Trial | |||
| Canada | 2963208 | Start Trial | |||
| European Patent Office | 3206716 | Start Trial | |||
| United Kingdom | 201418171 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
